
|Articles|November 3, 2014
So Who’s in Charge of Medicines in Brussels?
So now we know who is to do what on health issues in the new European Commission. Or do we?
Advertisement
So now we know who is to do what on health issues in the new European Commission. Or do we?
The furor that the new boss of the commission, Jean-Claude Juncker, unleashed with the plans for his new team, weeks before it took office, is still reverberating around Brussels. Peter O’ Donnell reports on the fallout in
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
DTP is Scaling Fast, the Safety Infrastructure is Not
2
U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels
3
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
4
Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration
5




